Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/05/13 | 8-K | Current report filing |
|
6 | |
| 12/04/13 | 8-K | Current report filing |
|
6 | |
| 12/02/13 | 8-K | Current report filing |
|
28 | |
| 11/20/13 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. |
|
5 | |
| 11/15/13 | 8-K | Current report filing |
|
15 | |
| 11/15/13 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
51 |
| 11/15/13 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
|
3 | |
| 11/13/13 | 8-K | Current report filing |
|
37 | |
| 11/08/13 | 8-K/A | Current report filing |
|
39 | |
| 11/07/13 | 8-K | Current report filing |
|
41 |
